These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23884069)

  • 1. Enhancing assessment and treatment of hepatitis C in the custodial setting.
    Post JJ; Arain A; Lloyd AR
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S70-4. PubMed ID: 23884069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C in Australian prisons: a national needs assessment.
    Mina MM; Herawati L; Butler T; Lloyd A
    Int J Prison Health; 2016; 12(1):3-16. PubMed ID: 26933988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting.
    Lloyd AR; Clegg J; Lange J; Stevenson A; Post JJ; Lloyd D; Rudge G; Boonwaat L; Forrest G; Douglas J; Monkley D
    Clin Infect Dis; 2013 Apr; 56(8):1078-84. PubMed ID: 23362288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector: The Hepatitis in Prisons Education program (HepPEd).
    Sheehan Y; Lafferty L; Tedla N; Byrne M; Dawson O; Stewart S; Leber B; Habraken N; Lloyd AR
    Int J Drug Policy; 2024 Jul; 129():104461. PubMed ID: 38971019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
    He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
    Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel.
    Lafferty L; Rance J; Dore GJ; Grebely J; Lloyd AR; Treloar C;
    Int J Drug Policy; 2021 Dec; 98():103379. PubMed ID: 34311138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.
    Skipper C; Guy JM; Parkes J; Roderick P; Rosenberg WM
    Gut; 2003 Oct; 52(10):1500-4. PubMed ID: 12970145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C Virus Elimination Program among Prison Inmates, Israel.
    Eisen L; Mor Z; Madar M; Rabinovitch R; Dadon Y; Sheffer R; Kaliner E; Goldstein L
    Emerg Infect Dis; 2023 Nov; 29(11):2358-2361. PubMed ID: 37877627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel.
    Ranieri R; Starnini G; Carbonara S; Pontali E; Leo G; Romano A; Panese S; Monarca R; Prestileo T; Barbarini G; Babudieri S;
    Infection; 2017 Apr; 45(2):131-138. PubMed ID: 28025726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of hepatitis B and C among prison population in Croatia].
    Burek V; Horvat J; Susić E; Mikulić R
    Acta Med Croatica; 2009 Dec; 63(5):447-50. PubMed ID: 20198906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison.
    Lafferty L; Treloar C; Guthrie J; Chambers GM; Butler T
    J Viral Hepat; 2017 Feb; 24(2):111-116. PubMed ID: 27778436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C).
    Rance J; Lafferty L; Treloar C;
    Harm Reduct J; 2021 Apr; 18(1):46. PubMed ID: 33902595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "You need a designated officer" - Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting.
    Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C;
    Int J Drug Policy; 2022 Aug; 106():103746. PubMed ID: 35636069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe.
    Stöver H; Meroueh F; Marco A; Keppler K; Saiz de la Hoya P; Littlewood R; Wright N; Nava F; Alam F; Walcher S; Somaini L
    BMC Public Health; 2019 Jan; 19(1):30. PubMed ID: 30621658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting.
    Overton K; Clegg J; Pekin F; Wood J; McGrath C; Lloyd A; Post JJ
    Int J Drug Policy; 2019 Oct; 72():123-128. PubMed ID: 30967329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain].
    Martín Sánchez V; Ferrer Castro V; Pallas Álvarez JR; Alonso Herrero LE; Andrés Honorato M; Coterillo González MJ; García Marcos LS; González Márquez J; Hernández Alonso I; LLanos Gallegos M; Mallada García E; Martínez Martínez ML; Morillo Pérez M; Pérez Martínez I; Valles Martínez J
    Rev Esp Salud Publica; 1998; 72(1):43-51. PubMed ID: 9477715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A descriptive model of patient readiness, motivators, and hepatitis C treatment uptake among Australian prisoners.
    Yap L; Carruthers S; Thompson S; Cheng W; Jones J; Simpson P; Richards A; Thein HH; Haber P; Lloyd A; Butler T
    PLoS One; 2014; 9(2):e87564. PubMed ID: 24586281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia.
    Gates JA; Post JJ; Kaldor JM; Pan Y; Haber PS; Lloyd AR; Dolan KA;
    J Urban Health; 2004 Sep; 81(3):448-52. PubMed ID: 15273267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Hepatitis C Cascade of Care in Prisoners-Is There Still Some Work to Do? Analysis of Two Large Penitentiaries in Northern Italy.
    Cambianica A; Marchese V; Pennati F; Faustinelli A; Migliorati M; Roda F; Spinetti A; Zaltron S; Fiorentini S; Caruso A; Quiros-Roldan E; Castelli F; Focà E
    Int J Environ Res Public Health; 2024 Jan; 21(1):. PubMed ID: 38248566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
    Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
    J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.